General Electric Company (NYSE:GE) was the target of some unusual options trading activity on Thursday. Traders bought 67,427 call options on the stock, Stock Ratings News reports. General Electric Company (NYSE:GE) has been the subject of a number of recent research reports. Analysts at TheStreet reiterated a “buy” rating on shares of General Electric Company…
Exxon Mobil Corporation (NYSE:XOM), the world’s largest publicly traded oil company, has agreed to disclose more information about the environmental risks of hydraulic fracturing, the process known as fracking. In an agreement with New York City’s pension funds, which control Exxon Mobile Corporation (NYSE:XOM) shares worth roughly $1.02 billion, the company agreed to report on…
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) announced that Vicente Anido, Jr., Ph.D., chairman and chief executive officer, will present at the 13th Annual Needham Healthcare Conference on Wednesday, April 9, 2014 at 12:10 pm Eastern Time in New York, NY. Dr. Anido will provide an Aerie overview and business update. Aerie Pharmaceuticals Inc (NASDAQ:AERI) stock performance was…
Shares of drugstore chain retailer, Rite Aid Corporation (NYSE:RAD) announced the acquisition of Boston-based Health Dialog Services Corporation from Bupa Ltd., a London-based healthcare company. Rite Aid Corporation (NYSE:RAD) stock performance was -0.47% in last session and finished the day at $6.36. Traded volume was 13.44million shares in the last session and the average volume…
Looking back to 160 days ago, ZIOPHARM Oncology Inc (NASDAQ:ZIOP) priced a 14,300,000 share secondary stock offering at $3.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Wednesday. ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)…
Can-Fite BioPharma Ltd. (NYSEMKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it has filed its 2013 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission. Can Fite Biopharma Ltd (ADR) (NYSEMKT:CANF) stock performance was 11.80% in last session and…
